Do Opioids Have a Role in the Management of Knee and Hip Osteoarthritis?
Researchers assessed pain relief and functional improvement in patients receiving opioids for knee or hip osteoarthritis.
Researchers assessed pain relief and functional improvement in patients receiving opioids for knee or hip osteoarthritis.
Researchers aimed to clarify the role of contextual effect in widely used nonpharmacologic, nonsurgical treatments for knee osteoarthritis by conducting a literature review of knee osteoarthritis trials.
In 2015 to 2018, 10.7% of US adults aged 20 years or older used one or more prescription pain medications.
For patients with chronic low back pain, tanezumab 10 mg significantly improves pain and function.
The ASIPP has published comprehensive, evidence-based guidelines for performing diagnostic and therapeutic facet joint interventions in the management of chronic spinal pain.
Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.
There are racial differences in pain management and pain outcomes for children seen in the emergency department for long-bone fractures.
Researchers assessed the effect of the opioid epidemic in Finnish patients with early inflammatory arthritides.
In this interview, Gregory P Nicholson, MD, discusses the applications of a novel joint preservation technology in glenohumeral osteoarthritis.
Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults ≥18 years old.